Supernus Pharmaceuticals
SUPN • NASDAQ
Supernus Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Jack A. Khattar, with a market cap of $2.8B.
Market Cap$2.8B
Employees652.0
CEOJack A. Khattar
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 5, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Supernus Pharmaceuticals FAQ
Common questions about Supernus Pharmaceuticals
Supernus Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 5, 2026 after market close. Analysts estimate revenue of $193.1M.
Supernus Pharmaceuticals has approximately 652 employees.